MAY 03, 2022 8:00 AM PDT

The development of GMP-manufactured Cas9 protein for therapeutic applications


Event Date & Time
Date:  May 03, 2022
Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST)
CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications. It is a nuclease-based genome editing system which has seen exponential growth in adoption for cell therapy development. To move your work from research through clinical trials and commercialization, access to GMP-grade CRISPR-Cas9 reagents that can meet your clinical needs and required regulatory standards is critical. In this presentation, we will explore the development of a GMP-grade Cas9 protein suitable for cell therapy applications. Then, we will focus on the manufacturing process controls and quality specifications needed to help ensure compliance to the appropriate regulatory standards. Finally, we will showcase its application in a T-cell workflow.
Learning Objectives
  • Discuss the development process of a GMP-manufactured Cas9 protein
  • Demonstrate the manufacturing process controls and quality specifications
  • Describe the application of GMP-manufactured Cas9 in primary T-cell workflow
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

You May Also Like
Loading Comments...
  • See More